nach oben

International Journal of Colorectal Disease

Erschienen in:

01.08.2014 | Review

The impact of smoking on HPV infection and the development of anogenital warts

verfasst von: Reto Kaderli, Beat Schnüriger, Lukas E. Brügger

Erschienen in: International Journal of Colorectal Disease | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The worldwide prevalence of human papillomavirus (HPV) infection is estimated at 9–13 %. Persistent infection can lead to the development of malignant and nonmalignant diseases. Low-risk HPV types are mostly associated with benign lesions such as anogenital warts. In the present systematic review, we examined the impact of smoking on HPV infection and the development of anogenital warts, respectively.

Methods

A systematic literature search was performed using MEDLINE database for peer-reviewed articles published from January 01, 1985 to November 30, 2013. Pooled rates of HPV prevalence were compared using the χ ² test.

Results

In both genders, smoking is associated with higher incidence and prevalence rates for HPV infection, whereas the latter responds to a dose-effect relationship. The overall HPV prevalence for smoking patients was 48.2 versus 37. 5 % for nonsmoking patients (p < 0.001) (odds ratio (OR) = 1.5, 95 % confidence interval (CI) 1.4–1.7). Smoking does also increase persistence rates for high-risk HPV infection, while this correlation is debatable for low-risk HPV. The incidence and recurrence rates of anogenital warts are significantly increased in smokers.

Conclusions

Most current data demonstrate an association between smoking, increased anogenital HPV infection, and development of anogenital warts. These data add to the long list of reasons for making smoking cessation a keystone of patient health.

WHO Vaccines against human papilloma virus. http://www.who.int/vaccines/en/hpvrd.shtml. Accessed April 01, 2014

Forcier M, Musacchio N (2010) An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatol Ther 23(5):458–476. doi:10.1111/j.1529-8019.2010.01350.x PubMed

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control 56 (Rr-2):1-24

Hathaway JK (2012) HPV: diagnosis, prevention, and treatment. Clin Obstet Gynecol 55(3):671–680. doi:10.1097/GRF.0b013e31825caa36 PubMed

Fleischer AB Jr, Parrish CA, Glenn R, Feldman SR (2001) Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis 28(11):643–647PubMed

Stanley M (2007) Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Br J Cancer 96(9):1320–1323. doi:10.1038/sj.bjc.6603695 PubMedCentralPubMed

Gross G, Pfister H (2004) Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193(1):35–44. doi:10.1007/s00430-003-0181-2 PubMed

Tay EH, Garland S, Tang G, Nolan T, Huang LM, Orloski L, Lu S, Barr E (2008) Clinical trial experience with prophylactic HPV 6/11/16/18 VLP vaccine in young women from the Asia-Pacific region. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 102(3):275–283. doi:10.1016/j.ijgo.2008.03.021

Patel H, Wagner M, Singhal P, Kothari S (2013) Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 13:39. doi:10.1186/1471-2334-13-39 PubMedCentralPubMed

10.

Scheinfeld N, Lehman DS (2006) An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 12(3):5PubMed

11.

Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L (2002) External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis Off Publ Infect Dis Soc Am 35(Suppl 2):S210–S224. doi:10.1086/342109

12.

Kodner CM, Nasraty S (2004) Management of genital warts. Am Fam Physician 70(12):2335–2342PubMed

13.

Wen LM, Estcourt CS, Simpson JM, Mindel A (1999) Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 75(5):312–316PubMedCentralPubMed

14.

Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, Ferreccio C, Matos E, Posso H, de Sanjose S, Shin HR, Sukvirach S, Lazcano-Ponce E, Munoz N, Meijer CJ, Franceschi S (2008) Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 37(3):536–546. doi:10.1093/ije/dyn033 PubMed

15.

Clarke M, Schiffman M, Wacholder S, Rodriguez AC, Hildesheim A, Quint W (2013) A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis 13:308. doi:10.1186/1471-2334-13-308 PubMedCentralPubMed

16.

Schabath MB, Villa LL, Lin HY, Fulp WJ, Lazcano-Ponce E, Salmeron J, Abrahamsen ME, Papenfuss MR, Quiterio M, Giuliano AR (2013) A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study. Int J Cancer J Int Cancer. doi:10.1002/ijc.28567

17.

Almonte M, Silva Idos S, Asare A, Gilham C, Sargent A, Bailey A, Turner A, Desai M, Kitchener HC, Peto J (2011) Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. J Med Virol 83(7):1238–1246. doi:10.1002/jmv.22085 PubMed

18.

Nielsen A, Iftner T, Munk C, Kjaer SK (2009) Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis 36(10):609–615. doi:10.1097/OLQ.0b013e3181a96d0e PubMedCentralPubMed

19.

Sarian LO, Hammes LS, Longatto-Filho A, Guarisi R, Derchain SF, Roteli-Martins C, Naud P, Erzen M, Branca M, Tatti S, de Matos JC, Gontijo R, Maeda MY, Lima T, Costa S, Syrjanen S, Syrjanen K (2009) Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sex Transm Dis 36(4):241–248. doi:10.1097/OLQ.0b013e3181935a7d PubMed

20.

Oh JK, Ju YH, Franceschi S, Quint W, Shin HR (2008) Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study. BMC Infect Dis 8:13. doi:10.1186/1471-2334-8-13 PubMedCentralPubMed

21.

Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, Stern ME, Lee SK, O'Reilly SF, Hawes SE, Kiviat NB, Koutsky LA (2007) Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 196(8):1128–1136. doi:10.1086/521192 PubMed

22.

Syrjanen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjanen S (2007) Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol 22(10):723–735. doi:10.1007/s10654-007-9180-8 PubMed

23.

Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ (2005) Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 14(6):1528–1533. doi:10.1158/1055-9965.epi-04-0754

24.

Minkoff H, Feldman JG, Strickler HD, Watts DH, Bacon MC, Levine A, Palefsky JM, Burk R, Cohen MH, Anastos K (2004) Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. J Infect Dis 189(10):1821–1828. doi:10.1086/383479 PubMed

25.

Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A (2003) Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ: Can Med Assoc J 168(4):421–425

26.

Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157(3):218–226PubMed

27.

Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, Lin HY, Quiterio M, Salmeron J, Lazcano-Ponce E, Villa LL, Giuliano AR (2011) Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 204(11):1711–1722. doi:10.1093/infdis/jir637 PubMedCentralPubMed

28.

Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Hernandez BY (2008) Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV cohort study. J Infect Dis 197(7):957–966. doi:10.1086/529207 PubMed

29.

Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J (2001) Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA: J Am Med Assoc 285(23):2995–3002

30.

Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123(8):1864–1870. doi:10.1002/ijc.23712 PubMed

31.

Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Goodman MT (2009) Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis: Off Publ Infect Dis Soc Am 48(5):536–546. doi:10.1086/596758

32.

Schmeink CE, Melchers WJ, Siebers AG, Quint WG, Massuger LF, Bekkers RL (2011) Human papillomavirus persistence in young unscreened women, a prospective cohort study. PLoS One 6(11):e27937. doi:10.1371/journal.pone.0027937 PubMedCentralPubMed

33.

Maucort-Boulch D, Plummer M, Castle PE, Demuth F, Safaeian M, Wheeler CM, Schiffman M (2010) Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer 126(3):684–691. doi:10.1002/ijc.24752 PubMed

34.

Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS (2006) Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol 164(2):176–183. doi:10.1093/aje/kwj165 PubMed

35.

Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7):423–428. doi:10.1056/nejm199802123380703 PubMed

36.

Louvanto K, Rintala MA, Syrjanen KJ, Grenman SE, Syrjanen SM (2010) Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis 202(3):436–444. doi:10.1086/653826 PubMed

37.

Nielsen A, Kjaer SK, Munk C, Osler M, Iftner T (2010) Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women. J Med Virol 82(4):616–623. doi:10.1002/jmv.21750 PubMed

38.

Phanuphak N, Teeratakulpisarn N, Pankam T, Kerr SJ, Barisri J, Deesua A, Rodbamrung P, Hongchookiat P, Chomchey N, Phanuphak P, Sohn AH, Ananworanich J, Palefsky JM (2013) Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr 63(4):472–479. doi:10.1097/QAI.0b013e3182918a5a PubMed

39.

Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, Abrahamsen M, Inserra P (2002) Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control: CCC 13(9):839–846PubMed

40.

Schabath MB, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Giuliano AR (2012) Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 21(1):102–110. doi:10.1158/1055-9965.epi-11-0591

41.

Kliucinskas M, Nadisauskiene RJ, Minkauskiene M (2006) Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecol Obstet Investig 62(3):173–180. doi:10.1159/000093572

42.

Kataja V, Syrjanen S, Yliskoski M, Hippelinen M, Vayrynen M, Saarikoski S, Mantyjarvi R, Jokela V, Salonen JT, Syrjanen K (1993) Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 138(9):735–745PubMed

43.

Hoang HT, Ishizaki A, Nguyen CH, Tran VT, Matsushita K, Saikawa K, Hosaka N, Pham HV, Bi X, Ta VT, Van Pham T, Ichimura H (2013) Infection with high-risk HPV types among female sex workers in northern Vietnam. J Med Virol 85(2):288–294. doi:10.1002/jmv.23456 PubMed

44.

Nielsen A, Munk C, Jorgensen H, Winther J, van den Brule A, Kjaer S (2013) Multiple-type human papillomavirus infection in younger uncircumcised men. Int J STD AIDS. doi:10.1177/0956462412472294 PubMed

45.

Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Delere Y (2013) Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 23(3):519–526. doi:10.1097/IGC.0b013e318285a4b2

46.

Brassard P, Jiang Y, Severini A, Goleski V, Santos M, Chatwood S, Lys C, Johnson G, Wong T, Kotaska A, Kandola K, Morrison H, Mao Y (2012) Factors associated with human papillomavirus infection among women in the Northwest Territories. Can J Public Health 103(4):e282–e287PubMed

47.

Bumbuliene Z, Alisauskas J (2012) Sexual behavior and high-risk human papillomavirus in 15- to 22-year-old Lithuanian women. Acta Obstet Gynecol Scand 91(4):511–513. doi:10.1111/j.1600-0412.2011.01334.x PubMed

48.

Monsonego J, Zerat L, Syrjanen K, Zerat JC, Smith JS, Halfon P (2012) Prevalence of type-specific human papillomavirus infection among women in France: implications for screening, vaccination, and a future generation of multivalent HPV vaccines. Vaccine 30(35):5215–5221. doi:10.1016/j.vaccine.2012.06.013 PubMed

49.

Pista A, de Oliveira CF, Cunha MJ, Paixao MT, Real O (2012) Risk factors for human papillomavirus infection among women in Portugal: the CLEOPATRE Portugal Study. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet 118(2):112–116. doi:10.1016/j.ijgo.2012.03.028

50.

Roset Bahmanyar E, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Jaisamrarn U, Limson GA, Garland SM, Szarewski A, Romanowski B, Aoki F, Schwarz TF, Poppe WA, De Carvalho NS, Harper DM, Bosch FX, Raillard A, Descamps D, Struyf F, Lehtinen M, Dubin G (2012) Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol 127(3):440–450. doi:10.1016/j.ygyno.2012.08.033 PubMed

51.

Roura E, Iftner T, Vidart JA, Kjaer SK, Bosch FX, Munoz N, Palacios S, Rodriguez MS, Morillo C, Serradell L, Torcel-Pagnon L, Cortes J, Castellsague X (2012) Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis 12:145. doi:10.1186/1471-2334-12-145 PubMedCentralPubMed

52.

Yetimalar H, Kasap B, Cukurova K, Yildiz A, Keklik A, Soylu F (2012) Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet 285(3):805–810. doi:10.1007/s00404-011-2034-3 PubMed

53.

Badano I, Pedrozo RW, Ruiz Diaz LS, Galuppo JA, Picconi MA, Campos RH, Liotta DJ (2011) Human papillomavirus (HPV) detection and Papanicolaou cytology in low-resource women in Posadas city, Misiones, Argentina. Rev Argent Microbiol 43(4):263–267. doi:10.1590/s0325-75412011000400005 PubMed

54.

Bell MC, Schmidt-Grimminger D, Jacobsen C, Chauhan SC, Maher DM, Buchwald DS (2011) Risk factors for HPV infection among American Indian and White women in the Northern Plains. Gynecol Oncol 121(3):532–536. doi:10.1016/j.ygyno.2011.02.032 PubMed

55.

Ferrera A, Tabora N, Flores Y, Zelaya A, Massuger L, Melchers WJ (2011) Assessment of HPV infection among female university students in Honduras via Roche linear array. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet 113(2):96–99. doi:10.1016/j.ijgo.2010.11.016

56.

Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN (2011) Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med 9:104. doi:10.1186/1741-7015-9-104 PubMedCentralPubMed

57.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F (2011) Prevalence and risk factors for human papillomavirus DNA in cervical cytology. Eur J Obstet Gynecol Reprod Biol 159(1):168–171. doi:10.1016/j.ejogrb.2011.06.021 PubMed

58.

Montalvo MT, Lobato I, Villanueva H, Borquez C, Navarrete D, Abarca J, Calaf GM (2011) Prevalence of human papillomavirus in university young women. Oncol Lett 2(4):701–706. doi:10.3892/ol.2011.290 PubMedCentralPubMed

59.

Shikova E, Todorova I, Ganchev G, Kouseva-Dragneva V, Kalascheva-Zaimova P (2011) Prevalence of human papillomavirus infection among female sex workers in Bulgaria. Int J STD AIDS 22(5):278–280. doi:10.1258/ijsa.2009.009362 PubMed

60.

Cercato MC, Mariani L, Vocaturo A, Carrone A, Terrenato I, Morano G, Benevolo M, Rollo F, Germelli C, Paolini F, Venuti A (2010) Predictors of human papilloma virus (HPV) infection in Italian women. J Med Virol 82(11):1921–1927. doi:10.1002/jmv.21887 PubMed

61.

Iftner T, Eberle S, Iftner A, Holz B, Banik N, Quint W, Straube AN (2010) Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study. J Med Virol 82(11):1928–1939. doi:10.1002/jmv.21910 PubMed

62.

Ripabelli G, Grasso GM, Del Riccio I, Tamburro M, Sammarco ML (2010) Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy. Cancer Epidemiol 34(2):162–167. doi:10.1016/j.canep.2009.12.010 PubMed

63.

Chan PK, Ho WC, Wong MC, Chang AR, Chor JS, Yu MY (2009) Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol 81(9):1635–1644. doi:10.1002/jmv.21575 PubMed

64.

Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, Markowitz LE, Giuliano AR (2009) Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 18(4):1077–1083. doi:10.1158/1055-9965.epi-08-0447

65.

Silva KC, Rosa ML, Moyse N, Afonso LA, Oliveira LH, Cavalcanti SM (2009) Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 104(6):885–891PubMed

66.

Valles X, Murga GB, Hernandez G, Sabido M, Chuy A, Lloveras B, Alameda F, de San JS, Bosch FX, Pedroza I, Castellsague X, Casabona J (2009) High prevalence of human papillomavirus infection in the female population of Guatemala. Int J Cancer 125(5):1161–1167. doi:10.1002/ijc.24444 PubMed

67.

Gonzalez C, Canals J, Ortiz M, Munoz L, Torres M, Garcia-Saiz A, Del Amo J (2008) Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women. Epidemiol Infect 136(2):215–221. doi:10.1017/s0950268807008382 PubMedCentralPubMed

68.

Lindau ST, Drum ML, Gaumer E, Surawska H, Jordan JA (2008) Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol 112(5):979–989. doi:10.1097/AOG.0b013e31818b0df2 PubMedCentralPubMed

69.

Nielson CM, Harris RB, Dunne EF, Abrahamsen M, Papenfuss MR, Flores R, Markowitz LE, Giuliano AR (2007) Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 196(8):1137–1145. doi:10.1086/521632 PubMed

70.

del Amo J, Gonzalez C, Losana J, Clavo P, Munoz L, Ballesteros J, Garcia-Saiz A, Belza MJ, Ortiz M, Menendez B, del Romero J, Bolumar F (2005) Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81(1):79–84. doi:10.1136/sti.2003.008060 PubMedCentralPubMed

71.

Beby-Defaux A, Bourgoin A, Ragot S, Battandier D, Lemasson JM, Renaud O, Bouguermouh S, Vienne Md Mde L, Agius G (2004) Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol 73(2):262–268. doi:10.1002/jmv.20085 PubMed

72.

Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, Rha SH, Jung SI, Kim JI, Jung KY, van Doorn LJ, Quint W (2004) Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 190(3):468–476. doi:10.1086/421279 PubMed

73.

Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF (2002) Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 185(1):28–35. doi:10.1086/338010 PubMed

74.

Lazcano-Ponce E, Herrero R, Munoz N, Hernandez-Avila M, Salmeron J, Leyva A, Meijer CJ, Walboomers JM (2001) High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 28(5):277–280PubMed

75.

Nyari T, Cseh I, Woodward M, Szollosi J, Bak M, Deak J (2001) Screening for human papillomavirus infection in asymptomatic women in Hungary. Hum Reprod (Oxford, England) 16(10):2235–2237

76.

Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL (2000) Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ: Can Med Assoc J 163(5):503–508

77.

Marrazzo JM, Koutsky LA, Stine KL, Kuypers JM, Grubert TA, Galloway DA, Kiviat NB, Handsfield HH (1998) Genital human papillomavirus infection in women who have sex with women. J Infect Dis 178(6):1604–1609PubMed

78.

Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R (1996) Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174(4):679–689PubMed

79.

Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, Knight JA, Murphy CM, Kiviat NB, Toomey KE et al (1994) The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 169(4):792–800PubMed

80.

Palefsky JM, Shiboski S, Moss A (1994) Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 7(6):599–606PubMed

81.

Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM (1993) Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 20(5):274–278PubMed

82.

Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM (1991) Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83(14):997–1003PubMed

83.

Rohan T, Mann V, McLaughlin J, Harnish DG, Yu H, Smith D, Davis R, Shier RM, Rawls W (1991) PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer. Int J Cancer 49(6):856–860PubMed

84.

Feldman JG, Chirgwin K, Dehovitz JA, Minkoff H (1997) The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 89(3):346–350. doi:10.1016/s0029-7844(97)00011-2 PubMed

85.

Simen-Kapeu A, La Ruche G, Kataja V, Yliskoski M, Bergeron C, Horo A, Syrjanen K, Saarikoski S, Lehtinen M, Dabis F, Sasco AJ (2009) Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Cote d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control: CCC 20(2):163–170. doi:10.1007/s10552-008-9230-x PubMed

86.

Werden J, Schnatz PF, Mandavilli S, Allen G, Murphy JL, Greene JF, Egan JF, Sorosky JI (2008) Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests. Journal Lower Genit Tract Dis 12(4):287–292. doi:10.1097/LGT.0b013e31817e307b

87.

Hajjaj AA, Senok AC, Al-Mahmeed AE, Issa AA, Arzese AR, Botta GA (2006) Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J 27(4):487–491PubMed

88.

O'Keefe EJ, Gardner A, Currie MJ, Garland S, Tabrizi S, Bowden FJ (2006) Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory. Sex Health 3(2):91–94PubMed

89.

de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Munoz N, Catala I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX (2003) Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30(10):788–793. doi:10.1097/01.olq.0000080177.82204.e0 PubMed

90.

Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJ, Meijer CJ, Bosch FX, Munoz N (2002) Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 86(5):705–711. doi:10.1038/sj.bjc.6600194 PubMedCentralPubMed

91.

Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ (2002) Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 78(3):215–218PubMedCentralPubMed

92.

Muckerman DR (1994) Subclinical human papillomavirus infection in a high-risk population. J Am Osteopath Assoc 94(7):545–550, 555-547PubMed

93.

Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA, Copeland C, Epp J et al (1993) Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis 20(5):279–285PubMed

94.

Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, Manos MM (1993) Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 20(5):286–289PubMed

95.

Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J (1992) Human papillomavirus prevalence in pregnancy. Obstet Gynecol 79(5 ( Pt 1)):649–656PubMed

96.

Meekin GE, Sparrow MJ, Fenwicke RJ, Tobias M (1992) Prevalence of genital human papillomavirus infection in Wellington women. Genitourin Med 68(4):228–232PubMedCentralPubMed

97.

Melbye M, Palefsky J, Gonzales J, Ryder LP, Nielsen H, Bergmann O, Pindborg J, Biggar RJ (1990) Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer 46(2):203–206PubMed

98.

Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK (1990) Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 28(5):507–513. doi:10.1203/00006450-199011000-00018 PubMed

99.

Sherman JF, Mount SL, Evans MF, Skelly J, Simmons-Arnold L, Eltabbakh GH (2008) Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus. Gynecol Oncol 110(3):396–401. doi:10.1016/j.ygyno.2008.05.015 PubMed

100.

Munk C, Svare EI, Poll P, Bock JE, Kjaer SK (1997) History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sexually transmitted diseases 24(10):567–572PubMed

101.

Brisson J, Roy M, Fortier M, Bouchard C, Meisels A (1988) Condyloma and intraepithelial neoplasia of the uterine cervix: a case-control study. Am J Epidemiol 128(2):337–342PubMed

102.

Hansen BT, Hagerup-Jenssen M, Kjaer SK, Munk C, Tryggvadottir L, Sparen P, Liaw KL, Nygard M (2010) Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect 86(4):258–262. doi:10.1136/sti.2009.038273 PubMed

103.

Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH, Wright RL, D'Souza G, Colie C, Strickler HD (2011) Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol 118(4):831–839. doi:10.1097/AOG.0b013e31821a0f4d PubMedCentralPubMed

104.

Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D (2004) Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 190(5):1241–1248. doi:10.1016/j.ajog.2003.12.037 PubMed

105.

Luu HN, Amirian ES, Beasley RP, Piller L, Chan W, Scheurer ME (2012) Association between smoking and size of anal warts in HIV-infected women. Int J STD AIDS 23(11):792–798. doi:10.1258/ijsa.2012.011420 PubMed

106.

Habel LA, Van Den Eeden SK, Sherman KJ, McKnight B, Stergachis A, Daling JR (1998) Risk factors for incident and recurrent condylomata acuminata among women. Popul-Based Stud Sex Transm Dis 25(6):285–292

107.

Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2(5):372–377. doi:10.1038/nri803 PubMed

108.

Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK (1993) Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103(5):1429–1432PubMed

109.

Sekhon HS, Wright JL, Churg A (1994) Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am J Physiol 267(5 Pt 1):L557–L563PubMed

110.

Feng Z, Hu W, Hu Y, Tang MS (2006) Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci U S A 103(42):15404–15409. doi:10.1073/pnas.0607031103 PubMedCentralPubMed

111.

Phillips DH, Hewer A, Scholefield JH, Skinner P (2004) Smoking-related DNA adducts in anal epithelium. Mutat Res 560(2):167–172. doi:10.1016/j.mrgentox.2004.02.014 PubMed

112.

Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, Gaitan E, Garcia M, Rawls WE (1989) Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 81(3):205–211PubMed

113.

Wiley DJ, Elashoff D, Masongsong EV, Harper DM, Gylys KH, Silverberg MJ, Cook RL, Johnson-Hill LM (2009) Smoking enhances risk for new external genital warts in men. Int J Environ Res Public Health 6(3):1215–1234. doi:10.3390/ijerph6031215 PubMedCentralPubMed

114.

Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygard J, Nygard M (2007) The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 196(10):1447–1454. doi:10.1086/522863 PubMed

115.

Daling JR, Sherman KJ, Weiss NS (1986) Risk factors for condyloma acuminatum in women. Sex Transm Dis 13(1):16–18PubMed

Titel: The impact of smoking on HPV infection and the development of anogenital warts
verfasst von: Reto Kaderli
Beat Schnüriger
Lukas E. Brügger
Publikationsdatum: 01.08.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: International Journal of Colorectal Disease / Ausgabe 8/2014
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-014-1922-y

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Extralevator abdominoperineal excision (ELAPE) for rectal cancer—short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warranted

Erratum to: Clinical competence in the surgery of rectal cancer: the Italian Consensus Conference

Confirmed pathogenic effect of a splice site variation in the MLH1 gene causing Lynch syndrome

A comparison of abdominal surgical outcomes between African–American and Caucasian Crohn’s patients

Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin

Anorectal complications and function in patients suffering from inflammatory bowel disease: a series of patients with long-term follow-up

Update Chirurgie